| USD ($) $ in Millions | LTM | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||||||||||
Net income (loss) before noncontrolling interests | $ 22,967 | $ 21,358 | $ 19,965 | $ 19,029 | ||||||||||||||
Net income before noncontrolling interests | - | - | - | - | ||||||||||||||
Adjustments to reconcile net income to net cash provided (used) by operating activities: | ||||||||||||||||||
Provision for credit losses | 3,770 | 3,658 | 4,334 | 5,399 | ||||||||||||||
Changes in fair value of MSRs and LHFS carried at fair value | 262 | 387 | 265 | 851 | ||||||||||||||
Depreciation, amortization and accretion | 7,675 | 7,713 | 7,558 | 6,271 | ||||||||||||||
Loans held for sale | - | - | - | - | ||||||||||||||
Trading assets | - | - | - | - | ||||||||||||||
Deferred income tax benefit | (2,387) | (1,870) | (911) | (50) | ||||||||||||||
Other, net | 206 | 6,229 | (1,737) | 7,149 | ||||||||||||||
Preferred stock released by ESOP | - | - | - | - | ||||||||||||||
Stock-based compensation | - | - | - | - | ||||||||||||||
Originations and purchases of loans held for sale | (46,583) | (48,197) | (37,992) | (30,365) | ||||||||||||||
Stock incentive compensation expense | - | - | - | - | ||||||||||||||
Excess tax benefits related to stock incentive compensation | - | - | - | - | ||||||||||||||
Originations of MHFS | - | - | - | - | ||||||||||||||
Proceeds from sales of and paydowns on loans originally classified as held for sale | 44,838 | 43,682 | 31,824 | 26,793 | ||||||||||||||
Proceeds from sales of and principal collected on LHFS | - | - | - | - | ||||||||||||||
Purchases of LHFS | - | - | - | - | ||||||||||||||
Net change in: | ||||||||||||||||||
Trading assets and liabilities | (43,338) | (52,956) | (20,491) | 3,349 | ||||||||||||||
Derivative assets and liabilities | - | - | (3,794) | 4,155 | ||||||||||||||
Accrued interest receivable | - | - | - | - | ||||||||||||||
Accrued interest payable | - | - | - | - | ||||||||||||||
Other assets | 9,224 | (4,106) | 3,192 | (6,838) | ||||||||||||||
Other accrued expenses and liabilities | 16,059 | 5,101 | 822 | 4,615 | ||||||||||||||
Net cash provided (used) by operating activities | 19,170 | (19,001) | 3,035 | 40,358 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||
Net change in: | ||||||||||||||||||
Federal funds sold and securities borrowed or purchased under resale agreements | - | (88,599) | - | - | ||||||||||||||
Federal funds sold and securities purchased under resale agreements | - | - | (27,022) | (12,729) | ||||||||||||||
Available-for-sale debt securities: | ||||||||||||||||||
Proceeds from sales | 16,750 | 7,176 | 27,901 | 14,651 | ||||||||||||||
Paydowns and maturities | 24,216 | 20,837 | 34,331 | 14,872 | ||||||||||||||
Purchases | (103,902) | (72,125) | (95,464) | (26,051) | ||||||||||||||
Held-to-maturity debt securities: | ||||||||||||||||||
Paydowns and maturities | 23,078 | 27,078 | 27,896 | 18,372 | ||||||||||||||
Purchases | 0 | 0 | 0 | (4,225) | ||||||||||||||
Equity securities: | ||||||||||||||||||
Equity securities, not held for trading: | ||||||||||||||||||
Proceeds from sales and capital returns | 4,361 | 4,551 | 3,812 | 2,244 | ||||||||||||||
Purchases | (10,216) | (9,381) | (8,363) | (5,811) | ||||||||||||||
Nonmarketable equity investments: | ||||||||||||||||||
Sales proceeds | - | - | - | - | ||||||||||||||
Purchases | - | - | - | - | ||||||||||||||
Loans: | ||||||||||||||||||
Loans originated, net of principal collected | (147,554) | (80,727) | 18,663 | 10,296 | ||||||||||||||
Proceeds from sales of loans originally classified as held for investment | 6,617 | 3,667 | 3,631 | 4,275 | ||||||||||||||
Purchases of loans | (1,706) | (1,655) | (843) | (1,637) | ||||||||||||||
Proceeds from sales (including participations) of loans originated for investment by banking subsidiaries | - | - | - | - | ||||||||||||||
Purchases (including participations) of loans by banking subsidiaries | - | - | - | - | ||||||||||||||
Principal collected on nonbank entities’ loans | - | - | - | 4,871 | ||||||||||||||
Loans originated by nonbank entities | - | - | - | (3,476) | ||||||||||||||
Net cash paid for acquisitions | - | - | - | - | ||||||||||||||
Proceeds from sales of foreclosed assets and short sales | - | - | - | - | ||||||||||||||
Proceeds from sales of foreclosed assets | - | - | - | - | ||||||||||||||
Net cash from purchases and sales of MSRs | - | - | - | - | ||||||||||||||
Other, net | 5,262 | 1,283 | (193) | 391 | ||||||||||||||
Net cash provided (used) by investing activities | (253,872) | (187,895) | (15,651) | 16,043 | ||||||||||||||
Cash flows from financing activities: | ||||||||||||||||||
Net change in: | ||||||||||||||||||
Deposits | 160,811 | 54,507 | 13,631 | (25,812) | ||||||||||||||
Federal funds purchased and securities loaned or sold under repurchase agreements | - | 137,452 | - | - | ||||||||||||||
Short-term borrowings | (56,725) | 15,619 | 18,710 | 38,414 | ||||||||||||||
Long-term debt: | ||||||||||||||||||
Proceeds from issuance | 34,948 | 31,340 | 29,014 | 49,071 | ||||||||||||||
Repayment | (25,849) | (34,470) | (55,582) | (22,886) | ||||||||||||||
Preferred stock: | ||||||||||||||||||
Proceeds from issuance | - | 0 | 1,997 | 1,722 | ||||||||||||||
Redeemed | (3,510) | (2,000) | (2,840) | (1,725) | ||||||||||||||
Cash dividends paid | (991) | (1,050) | (1,099) | (1,141) | ||||||||||||||
Proceeds from issuance of stock warrant | - | - | - | - | ||||||||||||||
Common stock: | ||||||||||||||||||
Proceeds from issuance | - | - | - | - | ||||||||||||||
Stock tendered for payment of withholding taxes | - | - | - | - | ||||||||||||||
Repurchased | (18,015) | (17,516) | (19,448) | (11,851) | ||||||||||||||
Cash dividends paid | (5,582) | (5,434) | (5,133) | (4,789) | ||||||||||||||
Common stock warrants repurchased | - | - | - | - | ||||||||||||||
Stock warrants: | ||||||||||||||||||
Excess tax benefits related to stock incentive compensation | - | - | - | - | ||||||||||||||
Net change in noncontrolling interests: | ||||||||||||||||||
Cash paid for purchase of Prudential's noncontrolling interest | - | - | - | - | ||||||||||||||
Net change in noncontrolling interests | - | - | - | - | ||||||||||||||
Other, net | (872) | (861) | (784) | (509) | ||||||||||||||
Net cash provided (used) by financing activities | 243,030 | 177,587 | (21,534) | 20,494 | ||||||||||||||
Net change in cash, cash equivalents, and restricted cash | 8,328 | (29,309) | (34,150) | 76,895 | ||||||||||||||
Net change in cash and due from banks | - | - | - | - | ||||||||||||||
Supplemental cash flow disclosures: | ||||||||||||||||||
Cash paid for interest | 40,686 | 39,806 | 43,619 | 30,431 | ||||||||||||||
Net cash paid (refunded) for income taxes | - | - | 1,664 | (1,786) | ||||||||||||||
Significant non-cash activities: | ||||||||||||||||||
Transfers from available-for-sale debt securities to held-to-maturity debt securities | 0 | 0 | 0 | - | ||||||||||||||
Transfers from loans to loans held for sale | - | - | 626 | - | ||||||||||||||
Reclassification of long-term debt to accrued expenses and other liabilities | - | $ 0 | $ 4,927 | - |